These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 403725)

  • 1. Peripheral blood lymphocytes in systemic lupus erythematosus. Relation to activity.
    Michalevicz R; Many A; Ramot B
    Acta Haematol; 1977 Mar; 57(4):199-205. PubMed ID: 403725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymphocyte alteration by procainamide: relation to drug-induced lupus erythematosus syndrome.
    Bluestein HG; Zvaifler NJ; Weisman MH; Shapiro RF
    Lancet; 1979 Oct; 2(8147):816-9. PubMed ID: 90917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced Fc-receptor bearing cells in peripheral bloods of patients with systemic lupus erythematosus and in rheumatoid synovial fluids.
    Nakai H; Morito T; Tanimoto K; Horiuchi Y
    J Rheumatol; 1977; 4(4):405-13. PubMed ID: 415139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of lymphocytotoxic antibodies to lymphopenia and parameters of disease activity in systemic lupus erythematosus.
    Utsinger PD
    J Rheumatol; 1976 Jun; 3(2):175-85. PubMed ID: 1084929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-dependent direct cytotoxicity of human lymphocytes. I. Studies on peripheral blood lymphocytes and sera of patients with systemic lupus erythematosus.
    Scheinberg MA; Cathcart ES
    Clin Exp Immunol; 1976 May; 24(2):317-22. PubMed ID: 1084243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases.
    Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N
    Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Drug-induced systemic lupus erythematosus (author's transl)].
    Schubothe H; Maas D
    Immun Infekt; 1977 Aug; 5(4):142-56. PubMed ID: 914314
    [No Abstract]   [Full Text] [Related]  

  • 8. Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus.
    Messner RP; Lindström FD; Williams RC
    J Clin Invest; 1973 Dec; 52(12):3046-56. PubMed ID: 4584345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The in vitro effect of thymic humoral factor and levamisole on peripheral blood lymphocytes in systemic lupus erythematosus patients.
    Michalevicz R; Many A; Ramot B; Trainin N
    Clin Exp Immunol; 1978 Jan; 31(1):111-5. PubMed ID: 639342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Generalized lupus erythematosus caused by methyl-phenyl-ethyl-hydantoin].
    Losada M; Meruane J
    Rev Med Chil; 1967 Jul; 95(7):380-2. PubMed ID: 4157386
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of Con A mitogenesis by serum from procainamide-treated patients and patients with systemic lupus erythematosus.
    Tannen RH; Cunningham-Rundles S
    Immunol Commun; 1982; 11(1):33-45. PubMed ID: 6178682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity of gamma-glutamyl transpeptidase in peripheral blood lymphocytes in systemic lupus erythematosus.
    Rovenský J; Stancíková M; Továrek J; Jaroskova L
    Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):111-4. PubMed ID: 6128965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytohemagglutinin response in systemic lupus erythematosus. Reconstitution experiments using highly purified lymphocyte subpopulations and monocytes.
    Utsinger PD; Yount WJ
    J Clin Invest; 1977 Sep; 60(3):626-38. PubMed ID: 330565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of some lymphocyte markers in B-cell chronic lymphocytic leukaemia and systemic lupus erythematosus (the B lymphocyte subset).
    Magyarlaki T; Losonczy H; Pár A
    Haematologia (Budap); 1990; 23(2):111-20. PubMed ID: 2148733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synovial fluid characteristics and the lupus erythematosus cell phenomenon in drug-induced lupus. Findings in three patients and review of pertinent literature.
    Vivino FB; Schumacher HR
    Arthritis Rheum; 1989 May; 32(5):560-8. PubMed ID: 2719730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antilymphocyte antibodies in systemic lupus erythematosus. Effect on lymphocyte surface characteristics.
    Messner RP; Kennedy MS; Jelinek JG
    Arthritis Rheum; 1975; 18(3):201-6. PubMed ID: 1095019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of the use of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography to assess the distribution of activated lymphocytes in patients with systemic lupus erythematosus.
    Nowak M; Carrasquillo JA; Yarboro CH; Bacharach SL; Whatley M; Valencia X; Takada K; Brust DG; Illei GG
    Arthritis Rheum; 2004 Apr; 50(4):1233-8. PubMed ID: 15077306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of DNA-binding lymphocytes in patients with systemic lupus erythematosus.
    Bankhurst AD; Williams RC
    J Clin Invest; 1975 Dec; 56(6):1378-85. PubMed ID: 1081549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lymphocytic and lymphocytoactive components in the etiopathogenic mechanisms of systemic lupus erythematosus. An analysis of the literature].
    Angela GC; Cavallo G; Fiorio C
    G Batteriol Virol Immunol; 1983; 76(1-6):25-42. PubMed ID: 6237017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphocyctes Tgammadelta in clinically normal skin and peripheral blood of patients with systemic lupus erythematosus and their correlation with disease activity.
    Robak E; Niewiadomska H; Robak T; Bartkowiak J; Błoński JZ; Woźniacka A; Pomorski L; Sysa-Jedrezejowska A
    Mediators Inflamm; 2001 Aug; 10(4):179-89. PubMed ID: 11577994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.